Understand the distinct strategic roles of the Clinical Investigation Plan and Investigator’s Brochure in a coherent medical device evidence program.
In medtech clinical strategy, the Investigator’s Brochure and Clinical Investigation Plan are often discussed together.
That is fair operationally. But strategically, they serve very different purposes — and treating them as interchangeable is dangerous.
The Investigator’s Brochure (IB) is a living document. It should evolve across the product lifecycle as new preclinical, clinical, and safety data emerge. It reflects the current state of knowledge around the product: what is known, what risks have been identified, and where uncertainty still remains and further work is warranted.
The Clinical Investigation Plan (CIP) is different. It is designed for a specific investigation. It has a defined objective, population, methodology, and endpoint framework. In that sense, it is meant to be finite: built to answer a particular question at a particular point in the product’s development.
That distinction is not just technical. It is strategic.
The IB is the evolving evidence narrative. The CIP is the focused plan to generate the next decision-shaping data.
When teams blur those intentions, the consequence is rarely just messy documentation. It can lead to misaligned evidence strategies, unfocused study design, and submissions where the scientific story and the clinical execution are not aligned nor adequately described.
The strongest programs do the opposite. They use the IB to show how product understanding is maturing over time. They use the CIP to translate that understanding into a targeted investigation with a clear purpose.
One document evolves with the product. The other is built to deliver a defined proof point.
That is the difference between documentation as a regulatory exercise and documentation as a strategic asset.
We think this matters even more now, as evidence expectations continue to rise across the device lifecycle. The organisations that stand out are not the ones producing more documents. They are the ones ensuring each document does the job it is meant to do — clearly, deliberately, and in service of the broader clinical and regulatory strategy.